Recruitment and Informed Consent for Experimental Gene Therapy Trials When New FDA-Approved Treatments are not Widely Available.
| Published in: | American Journal of Bioethics Vol. 25; no. 4; pp. 149 - 152 |
|---|---|
| Main Authors: | , |
| Format: | Journal Article |
| Published: |
Taylor & Francis Ltd
Apr2025
|
| Online Access: | View this record in EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=184339998&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 184339998 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 15265161 FKZ jtl: American Journal of Bioethics issn: 15265161 maglogo: N pubinfo: dt: Apr2025 vid: 25 iid: 4 pid: 377 pub: Taylor & Francis Ltd place: Philadelphia, Pennsylvania artinfo: ui: 184339998 10.1080/15265161.2025.2470671 184339998 ppf: 149 ppct: 3 formats: fmt: – @attributes: type: T – @attributes: type: P tig: atl: Recruitment and Informed Consent for Experimental Gene Therapy Trials When New FDA-Approved Treatments are not Widely Available. aug: au: Slabaugh, Benjamin Anderson, Emily E. affil: Neurocrine Biosciences sug: subj: Anemia, Sickle Cell Therapy Gene Therapy Clinical Trials Research Subject Recruitment Ethical Issues Consent (Research) United States Food and Drug Administration Drug Approval Drug Development Health Care Costs Insurance, Health Insurance Coverage Professional-Patient Relations Trust pubtype: Academic Journal doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|